PD39-11 IMPROVED SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA IN THE CONTEMPORARY IMMUNOTHERAPY ERA: A NATIONAL POPULATION-BASED ANALYSIS

Nirmish Singla,Ryan Hutchinson,Rashed Ghandour,Yuval Freifeld,Dong Fang,Arthur I. Sagalowsky,Yair Lotan,Aditya Bagrodia,Vitaly Margulis,Hans J. Hammers,Solomon L. Woldu

PD39-11 IMPROVED SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA IN THE CONTEMPORARY IMMUNOTHERAPY ERA: A NATIONAL POPULATION-BASED ANALYSIS

2020

Nirmish Singla
Ryan Hutchinson
Rashed Ghandour
Yuval Freifeld
Dong Fang
Arthur I. Sagalowsky
Yair Lotan
Aditya Bagrodia
Vitaly Margulis
Hans J. Hammers
Solomon L. Woldu

INTRODUCTION AND OBJECTIVE:Immune checkpoint inhibitors (ICI) were approved for treating metastatic renal cell carcinoma (mRCC) in 2015. Current use of cytoreductive nephrectomy (CN) is guided by e...

Keywords:

Urology
Immunotherapy
improved survival
cytoreductive nephrectomy
Renal cell carcinoma
Medicine
population based

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations